What is Ligand Pharmaceuticals Incorporated's share price today?
Ligand Pharmaceuticals Incorporated (LGND) share price today is $305.08 as of October 27, 2026 at 12:20 AM IST. The stock touched a day high of $307.97 and a day low of $304.05.What exchange does Ligand Pharmaceuticals Incorporated stock trade on, and under what ticker symbol?
Ligand Pharmaceuticals Incorporated stock trades on NASDAQ under the ticker symbol LGND.What is Ligand Pharmaceuticals Incorporated's market capitalization?
Ligand Pharmaceuticals Incorporated's market capitalization is $6.05B as of October 27, 2026 at 12:20 AM IST.What is Ligand Pharmaceuticals Incorporated's price-to-earnings (P/E) ratio?
Ligand Pharmaceuticals Incorporated's price-to-earnings (P/E) ratio is 31.98 as of October 26, 2026.What is Ligand Pharmaceuticals Incorporated's price-to-book (P/B) ratio?
Ligand Pharmaceuticals Incorporated's price-to-book (P/B) ratio is 6.15 as of October 26, 2026.Can Indian investors buy Ligand Pharmaceuticals Incorporated shares?
Yes, You can buy Ligand Pharmaceuticals Incorporated shares from India through Tickertape, via our partnership with ViewTrade IFSC under the IFSCA Global Access framework, subject to RBI’s Liberalised Remittance Scheme (LRS) limits.How can I invest in Ligand Pharmaceuticals Incorporated shares from India?
Indian investors can buy Ligand Pharmaceuticals Incorporated shares in three steps: 1. Search Ligand Pharmaceuticals Incorporated on the Tickertape app and tap Invest. 2. Complete your one-time digital KYC. 3. Fund your account and buy from as low as $1 via fractional shares.How does USD-INR currency movement affect returns from Ligand Pharmaceuticals Incorporated shares for Indian investors?
Since Ligand Pharmaceuticals Incorporated trades in USD, an Indian investor's INR returns depend on both the stock's price movement and the USD-INR exchange rate. If the rupee depreciates against the dollar, INR returns are boosted beyond the stock's USD return; if the rupee appreciates, INR returns are reduced.What is the minimum amount required to invest in Ligand Pharmaceuticals Incorporated shares via Tickertape?
Indian investors can start investing in Ligand Pharmaceuticals Incorporated (LGND) shares from as little as $1 through fractional ownership on Tickertape - for example, $10 buys approximately 0.0327 shares at the current price of $305.08.
Key Metrics
Key Metrics
Close price divided by the earnings per share for the trailing twelve months
Close price divided by the book value per share at the end of the most recent quarter
Net profit earned per share over the trailing twelve months (sum of the last 4 quarters)
Price-to-Earnings (P/E) ratio divided by the forecasted annual earnings per share (EPS) growth rate over the next five years
Net profit divided by the total revenue for the most recent financial year
Annual dividend per share for the trailing twelve months divided by the close price
Based on 11 analysts reports
Price Upside
+13.91%
Earnings Growth
+37.85%
Rev. Growth
+7.77%
Company Profile
Company Profile
Forecast
Forecast
Price
Revenue
Earnings
Price Forecast
Price Forecast
All values in $
All values in $
Revenue Forecast
Revenue Forecast
The next fiscal year's mean estimate implies 7.77% growth, versus a trailing 3-year CAGR of 10.96%.
All values in $ Million
All values in $ Million
Earnings Per Share Forecast
Earnings Per Share Forecast
The next fiscal year's mean estimate implies 37.85% growth, versus a trailing 3-year CAGR of 14.98%.
All values in $
All values in $
Financials
Financials
Income
Balance Sheet
Cash Flow
| Financial Year | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 30.97 | 41.53 | 51.81 | 42.81 | 45.33 | 47.62 | 115.46 | 59.66 | 51.72 | 63.69 |
| Gross Profit | 19.91 | 56.85 | 39.31 | 39.97 | 40.48 | 44.72 | 90.64 | 85.65 | 49.64 | 60.47 |
| Net Income | 86.13 | -51.91 | -7.17 | -31.08 | -42.45 | 4.84 | 117.27 | 44.78 | -13.34 | 48.50 |
| Net Profit Margin | 278.06% | -124.99% | -13.84% | -72.61% | -93.64% | 10.17% | 101.56% | 75.05% | -25.80% | 76.15% |
Peers
Peers & Comparison
Peers & Comparison
HealthcareBiotechnology
Valuation
Returns
Forecast
| Stock | PE TTMPE TTM | PBPB | PEG RatioPEG Ratio |
|---|---|---|---|
| Ligand Pharmaceuticals Incorporated | 31.98 | 6.15 | 1.52 |
| AbbVie Inc | 80.68 | 50.45 | 0.53 |
| Amgen Inc | 27.28 | 17.56 | 2.28 |
The 12-month consensus target implies 13.91% growth, versus a trailing 3-year CAGR of 80.80%.